Starting Leqembi or Kisunla for early Alzheimer’s disease adds a new MRI schedule to the care plan, whether you’re the one starting treatment or helping coordinate it for someone you love. These scans are how your doctor catches a side effect called ARIA before it becomes serious. Here’s what to expect from each appointment.
Key Takeaways
- ARIA monitoring MRI scans catch silent changes — ARIA usually causes no symptoms, so scheduled scans are often the only way to detect it early.
- The schedule is heaviest in the first few months — most monitoring scans happen during the early phase of treatment, when ARIA risk is highest.
- The FDA added an earlier scan for extra safety — an additional monitoring MRI was added between the second and third infusion after review of serious cases.
- Treatment is generally paused until scans are reviewed — infusions or injections are held until your care team confirms the MRI looks safe to proceed.
- Scheduling has to work around your infusion calendar — monitoring scans are timed to specific treatment milestones, so appointments often need to be booked in advance.
- Coverage varies by plan — checking your benefits ahead of a multi-scan treatment year can help you plan for costs.
Leqembi and Kisunla: Newer Treatments for Early Alzheimer’s Disease
“Early” Alzheimer’s disease refers to the mild cognitive impairment or mild dementia stage, confirmed through testing that shows amyloid plaque buildup in the brain. It’s the specific stage both Leqembi and Kisunla are approved to treat.
How Long These Treatments Have Been Available
Leqembi (lecanemab) and Kisunla (donanemab) are among the newest FDA-approved treatments for early Alzheimer’s disease.
- Leqembi received traditional FDA approval in July 2023, making it the first new Alzheimer’s treatment with full approval in roughly two decades.
- Kisunla followed a year later, receiving its own traditional approval in July 2024.
How These Medications Work
Both medications work the same way. They target and help clear amyloid plaques, a hallmark buildup associated with Alzheimer’s disease, from the brain. Removing that buildup can also affect the small blood vessels around it, which is why both drugs come with an FDA-required MRI monitoring schedule built into treatment from day one.
What Your ARIA Monitoring Schedule May Look Like
Your Baseline and Early Monitoring Scans
Every ARIA monitoring plan starts with a baseline brain MRI before your first dose, followed by several additional scans concentrated in the early months of treatment.
- Leqembi’s patient materials describe one MRI before treatment and four more in the months that follow, timed to specific infusion milestones.
- Kisunla follows a similar early monitoring window on its own dosing schedule.
Your prescribing physician sets the exact timing based on which therapy you’re starting.
Why the Schedule Was Updated
Each part of the schedule serves a purpose. The FDA required an additional, earlier monitoring MRI between the second and third infusion of Leqembi after reviewing cases of serious ARIA-E that developed earlier in treatment than expected. That change reflects a broader pattern with these therapies: ARIA risk is highest in the first several months, which is why scans are concentrated there rather than spread evenly across a full year.
Scheduling Your Brain MRI Around Treatment
Because monitoring scans are timed close to upcoming infusions, appointments often need to go on the calendar several weeks in advance. A few things to keep in mind as you plan:
- Book around your infusion dates first, since results need to be reviewed before your next dose.
- Bring your treatment schedule to your imaging appointment so scheduling staff can plan future scans around it.
- Ask about scan length ahead of time if you have questions about positioning, contrast, or what to expect during the appointment.
- Confirm insurance coverage early given how many scans a treatment year can involve.
What ARIA Monitoring Is Watching For
ARIA, short for amyloid-related imaging abnormalities, describes brain changes that occasionally develop during treatment with amyloid-clearing therapies. There are two types. ARIA-E involves fluid swelling in brain tissue. ARIA-H involves small spots of bleeding. Most cases cause no noticeable symptoms at all, which is why regular brain MRI is such an important part of these treatment plans. A scan can catch changes long before you’d ever feel anything, giving your care team a chance to respond early.
What Your Care Team Is Looking For on Each Scan
Each monitoring MRI is read specifically for signs of swelling or bleeding. Your neurologist or infusion center reviews the images before your next dose is given. The results determine whether treatment continues as planned, gets adjusted, or gets paused.
Frequently Asked Questions About ARIA Monitoring MRI Scans
What is ARIA?
ARIA stands for amyloid-related imaging abnormalities, a set of brain changes, either swelling or small bleeding spots, that can develop during treatment with amyloid-clearing therapies like Leqembi and Kisunla. Most cases are found on a scan before they’d ever cause a symptom, which is the reason brain MRI monitoring is built into these treatment plans from the start.
How many MRI scans will I need during treatment?
The number varies by therapy and by your individual risk factors, but plan on a baseline scan before starting treatment and several more concentrated in the first few months. Your prescribing physician will lay out the specific schedule for the medication you’re on.
Does insurance cover ARIA monitoring MRI scans?
Coverage depends on your specific plan, since these are medically necessary scans tied to an FDA-required monitoring schedule rather than elective imaging. It’s worth checking your benefits before treatment starts, given how many brain MRI for Alzheimer’s treatment monitoring appointments a full year can include.
What happens if ARIA appears on my scan?
Your care team reviews the images and decides next steps based on what they see and whether you have any symptoms. In many cases, treatment can continue with closer monitoring, though your physician may pause or adjust dosing depending on what the scan shows.
Can I schedule all my monitoring scans in advance?
Some centers can help you plan several appointments at once around your known infusion dates, which can make a busy treatment year easier to manage. You can ask your imaging center directly about batch scheduling when you set up your first appointment.
Planning Ahead for Your ARIA Monitoring MRI
A treatment plan built around frequent scans works best when scheduling is simple and appointments fit your infusion calendar.
Reach out to our team at University Medical Imaging in Sacramento with questions about scheduling your ARIA monitoring scans.